Why is "Adjuvant therapy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-28 10:23:10
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Adjuvant_therapy entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-28 and was most recently seen on 2026-03-28.
Wikipedia Overview
Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to the presence of undetected disease. If known disease is left behind following surgery, then further treatment is not technically adjuvant.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer - Yahoo Finance
-
From Prognostic Marker to Clinical Tool: Can ctDNA Inform Adjuvant Therapy in Breast Cancer? - ASCO Daily News
-
MSD-Moderna Phase III readout backs personalised mRNA neoantigen combination adjuvant therapy for melanoma - European Pharmaceutical Review
-
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease - PR Newswire
-
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post
-
FDA Weighs Giredestrant as Adjuvant Therapy for Early Breast Cancer - Medical Professionals Reference
-
No Survival Gain With Adjuvant Therapy in Stage III Melanoma - Medscape
-
Managing Progression After Adjuvant Therapy in Advanced RCC - OncLive
-
Adjuvant Therapy in Renal Cell Carcinoma: Who Benefits and Who Is Overtreated - Oncodaily
-
FDA approves atezolizumab as adjuvant therapy for MIBC guided by ctDNA - Urology Times
-
New Dopamine Agonist Shows Potential for Adjuvant Therapy in Parkinson's Disease - Neurology Today
-
Chemotherapy-free adjuvant treatment preserves quality of life in HER2-positive early breast cancer - ESMO Daily Reporter
-
Perioperative Immunotherapy Versus Risk-Adapted Adjuvant Therapy in MIBC - Patrizia Giannatempo & Thomas Powles - UroToday
-
Selpercatinib Shows Promise as Adjuvant Therapy in Early-Stage NSCLC - Oncology News Central
-
IBCFS With Prosigna-Guided Adjuvant Therapy Is Noninferior to Chemoendocrine Therapy in ER+/HER2– Early Breast Cancer - OncLive
-
Kent Shih, MD, on Adjuvant Therapy in Melanoma: How Does GEP Testing Factor In? - The ASCO Post
-
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs - Medscape
-
Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine - PR Newswire
-
IMvigor011 Explores ctDNA Dynamics in Adjuvant Therapy for Urothelial Cancer - Thomas Powles - UroToday
-
Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy - The ASCO Post
-
Adjuvant Therapy Advances in HR+ Breast Cancer: Updates From NATALEE, monarchE, and lidERA - Docwire News
-
Balancing Benefit and Toxicity in Adjuvant Therapy for Cervical Cancer - Oncology Nursing News
-
Adjuvant Therapy Considerations in Renal Cell Carcinoma - OncLive
-
Immediate Versus Delayed Breast Reconstruction: Integrating Oncologic Safety, Adjuvant Therapy Considerations, and Aesthetic Outcomes in Multidisciplinary Breast Cancer Care - Cureus
-
Lymph Node Status & Tumor Size in Lung Cancer Adjuvant Therapy - OncLive
-
Counseling Patients on PCR, Residual Disease, and the Role of Adjuvant Therapy After DFLOT - CancerNetwork
-
Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer - Eli Lilly and Company
-
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial - Nature
-
Analysis of ctDNA in IMvigor011 Informs Adjuvant Therapy Decisions for Muscle-Invasive Bladder Cancer - Matthew Galsky - UroToday
-
Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation - Frontiers
-
ASCO 2026: Evolving Adjuvant Therapy in Early Breast Cancer - Medscape
-
Adjuvant therapy for renal cell carcinoma: lessons from past failures and new opportunities in the era of immune checkpoint inhibition - Frontiers
-
Early Non-Contiguous Pachymeningeal Dissemination of Isocitrate Dehydrogenase (IDH)-Wildtype Giant Cell Glioblastoma: A Rare Finding During Adjuvant Therapy - Cureus
-
Peliosis Hepatis Presenting As Pseudometastatic Liver Lesions During Adjuvant Therapy for Colon Cancer: A Case Report - Cureus
-
Final Results from a Study of Adjuvant Therapy in Stage III Melanoma - NEJM Clinician
-
Long-Term Follow-Up and Surveillance After Adjuvant Therapy - OncLive
-
Nabil Ismaili: Biomarker-Guided Adjuvant Therapy in Stage II/III Colon Cancer - Oncodaily
-
Barriers and Breakthroughs Ahead for Personalizing Adjuvant Therapy: Michael Hassett, MD - The American Journal of Managed Care
-
Liquid biopsy-guided adjuvant therapy in bladder cancer - Nature
-
Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-Negative Breast Cancer - OncLive
-
Adjuvant Therapy Confers Postoperative ctDNA Clearance, DFS Benefit in CRC - CancerNetwork
-
Honey and cancer: from traditional medicine to modern adjuvant therapy - Frontiers
-
Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery - PNAS
-
Rupam Manna: Evolution of Adjuvant Therapy in Breast Cancer - Oncodaily
-
Use of exosomes as adjuvant therapy in the reconstruction of traumatic eyelid wounds: A case report - www.elsevier.com
-
Localized GIST: Adjuvant therapy improves overall survival only in high-risk disease - Vera Health
-
FDA Grants Priority Review to Adjuvant Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer - OncLive
-
Optimizing Adjuvant IO in Renal Cell Carcinoma Post-Nephrectomy - Targeted Oncology
-
PEGASUS Trial at ESMO 2025: Liquid Biopsy-Guided Adjuvant Therapy in Resected Colon Cancer - Oncodaily
-
Perioperative Pembrolizumab Plus Surgery and Risk-Adapted Standard Adjuvant Therapy Shows Benefit in Locally Advanced Head and Neck Cancer - The ASCO Post
-
Adjuvant Pembrolizumab in Merkel Cell Carcinoma - The ASCO Post
-
Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer - Memorial Sloan Kettering Cancer Center
-
The Adjuvant Therapy of Pemphigus : Archives of Dermatology - Ovid
-
Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post
-
Berberine Shows Promise as Adjuvant Therapy for Lung Cancer, Review Finds - Medical Dialogues
-
Michelino De Laurentiis: Constructive Scientific Dialogue on the Future of Adjuvant Therapy in HR+/HER2– Breast Cancer - Oncodaily
-
[ESMO 2025] Kisqali adjuvant therapy maintains efficacy at 5th year - Korea Biomedical Review
-
Antonio Calles: ELEVATE Trial - Ensartinib as Adjuvant Therapy in Stage IB-IIIB ALK+ NSCLC - Oncodaily
-
Ki-67 Index: A Powerful Prognostic, But Not Predictive, Marker in Post-NAC Adjuvant Therapy - Pharmacy Times
-
Impact of Margin Assessment Method on Adjuvant Therapy and Recurrence in Early Oral Cancer - Wiley Online Library
-
Debate Over Adjuvant Therapy for Resectable Liver Cancer Divides Experts - Oncology News Central
-
Adjuvant Therapy for Stage III Melanoma: What’s the Right Approach? - Oncology News Central
-
ctDNA-Guided Adjuvant Therapy in Stage III Colon Cancer: Impact on Recurrence-Free Survival and Treatment Exposure - Vera Health
-
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer - Nature
-
FDA Approval of Cemiplimab-rwlc as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma Post-Surgery and Radiation - Vera Health
-
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New England Journal of Medicine
-
Adjuvant Therapies May Mitigate Risk of Recurrence in Women With Early-Stage Breast Cancer - The American Journal of Managed Care
-
Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score matched population - Nature
-
ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide - UroToday
-
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - The New England Journal of Medicine
-
Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC? - ASCO Daily News
-
“One of the Harder Decisions”: Adjuvant Therapy for Stage II Melanoma - Oncology News Central
-
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma - Science | AAAS
-
High-Risk MIBC: Adjuvant Therapy Options After Radical Cystectomy - Targeted Oncology
-
Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade - Nature
-
Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node-negative, human epidermal growth factor receptor 2–positive breast cancer: A Surveillance, Epidemiology, and End Results population-based study - Wiley & Sons
-
Considering Adjuvant Therapy For Melanoma? What to Know - HealthCentral
-
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years - The New England Journal of Medicine
-
Two Adjuvant Therapy Studies Show Divergent Outcomes With PD-1 Inhibitors in Renal Cell Carcinoma - The ASCO Post
-
Fallout From Failed Phase 3 Trial: Adjuvant Therapy “Not the Most Appropriate Option” for All Stage III Melanomas - Oncology News Central
-
How to Select Patients for Adjuvant Therapy After Radical Prostatectomy and How to Treat Them? "Presentation" - Jason Efstathiou - UroToday
-
The Landmark Series: Melanoma and Adjuvant Therapy - Springer Nature Link
-
Roundtable Roundup: Adjuvant Therapy for HR+, HER2- Breast Cancer - Targeted Oncology
-
Questions still remain on optimal adjuvant therapy in advanced melanoma - ESMO Daily Reporter
-
Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National Cancer Institute (.gov)
-
Monitoring Neo-Adjuvant Therapy Efficacy in Solid Tumors - Inside Precision Medicine
-
Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer - National Cancer Institute (.gov)
-
Balancing Quality of Life: Adjuvant Therapy Toxicity in Melanoma Adjuvant Immunotherapy - OncLive
-
Can De-Escalation of Adjuvant Therapy Be Considered for Older Adults with Breast Cancer? - NEJM Evidence
-
Early Non-Small Cell Lung Cancer and Adjuvant Therapy - Cure Today
-
Aspirin as Adjuvant Therapy for Breast Cancer - The ASCO Post
-
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
-
Dr Halmos on Selection Criteria for Adjuvant Therapy After Chemo/IO in NSCLC - OncLive
-
Dr. Panagiotis J Vlachostergios Highlights from VIRO 2025 on Biomarkers for adjuvant therapy benefit in RCC - Oncodaily
-
Dr Lopetegui-Lia on Adjuvant Therapy for Early-Stage TNBC With Residual Disease - OncLive
-
Choosing Which Patients Should Receive Adjuvant Therapy for RCC - Targeted Oncology
-
Adjuvant Therapy for Residual Disease in Early-Stage Triple-Negative Breast Cancer - ASCO Daily News
-
Adjuvant Therapy in Colorectal Cancer and the Role of Minimal Residual Disease - ASCO Daily News
-
Personalizing adjuvant therapy for patients with colorectal cancer - Nature
-
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer - The New England Journal of Medicine
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.